CLINICAL TRIALS PROFILE FOR RAZADYNE ER
✉ Email this page to a colleague
All Clinical Trials for RAZADYNE ER
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00227994 ↗ | Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2003-04-01 | This study will evaluate the effectiveness of treatment with acetylcholinesterase inhibitors in improving cognitive function and overall rehabilitation in elderly stroke survivors. |
NCT00227994 ↗ | Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke | Completed | University of Pittsburgh | Phase 4 | 2003-04-01 | This study will evaluate the effectiveness of treatment with acetylcholinesterase inhibitors in improving cognitive function and overall rehabilitation in elderly stroke survivors. |
NCT00232349 ↗ | Efficacy of Galantamine to Treat Schizophrenia | Terminated | Seattle Institute for Biomedical and Clinical Research | Phase 4 | 2005-02-01 | The purpose of this study was to determine if treatment with adjunctive galantamine is effective in the reduction of functional impairments in patients with schizophrenia and schizoaffective disorder. It was hypothesized that adjunctive galantamine would yield clinically significant improvements from baseline to end of study on a measure of quality of life and a measure of independent living skills. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RAZADYNE ER
Condition Name
Clinical Trial Locations for RAZADYNE ER
Trials by Country
Clinical Trial Progress for RAZADYNE ER
Clinical Trial Phase
Clinical Trial Sponsors for RAZADYNE ER
Sponsor Name